A cloud LIMS that tracks samples, tests results, and manages inventory for life science research, industrial QC labs, and biotech/NGS. Includes regulatory support for CLIA and HIPAA, Part 11 and ISO 17025. The quality, security, traceability, and traceability for samples is crucial to a lab's success. Laboratory professionals can use the Lockbox LIMS system to manage their samples. They have full visibility of every step of the sample's journey from accession to long-term storage. LIMS analysis is more than just tracking results. Lockbox's multilayered sample storage and location management functionality lets you define your lab's storage structure using a variety location options: rooms and storage units, shelves and racks, boxes and boxes.
Learn more
SAP Cloud ERP is an enterprise-grade ERP platform designed for organizations that need real-time control, predictable operations, and a modern cloud foundation without the cost and complexity of traditional systems. Built on SAP HANA’s in-memory architecture, it delivers instant visibility across finance, supply chain, manufacturing, and procurement, enabling teams to make accurate, data-driven decisions at speed.
This solution provides continuous, automated updates and built-in best practices so companies can adopt new capabilities without disruptive upgrade cycles. Embedded AI, machine learning, and advanced analytics support intelligent automation, scenario planning, and risk reduction across every operational process. Native integration with SAP Business Technology Platform and a broad ecosystem of enterprise applications ensures extensibility without customization-heavy technical debt.
SAP Cloud ERP (SAP S/4HANA Cloud Public Edition) is engineered for organizations seeking the benefits of standardization, faster time-to-value, and global scalability. Its secure, multi-tenant cloud architecture ensures consistent performance, regulatory compliance, and lower total cost of ownership. With strong support for manufacturing, distribution, and service-centric operations, it equips IT and business leaders with a reliable platform to simplify their landscape, eliminate legacy bottlenecks, and power sustainable long-term growth.
Learn more
GPT-Rosalind
GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.
Learn more
BenevolentAI
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Learn more
